3457501e-figure-01 (3457501e Figure 01)
Losartan Potatssium
Product Images NDC 58517-240
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Losartan Potatssium (NDC 58517-240). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by New Horizon Rx Group, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
3457501e-figure-02 (3457501e Figure 02)
This appears to be a result summary of a clinical trial comparing the medications Atenolol and Losartan Potassium. The data shows that 9% of the patients achieved the primary endpoint, and the adjusted risk reduction was 13% with a p-value of 0.021. The table shows various study months and potentially some numerical results associated with them, but without more context it is difficult to determine their meaning.*
3457501e-figure-03 (3457501e Figure 03)
This text is not-available since it only lists medication names and some symbols.*
3457501e-figure-04 (3457501e Figure 04)
3457501e-figure-05 (3457501e Figure 05)
This document is describing the results of a clinical trial involving Losartan Potassium Tablet and a placebo. It states that 9% of patients experienced an event, and that there was a 16.1% risk reduction with Losartan Potassium Tablet compared to the placebo. The value of p is 0.022. The meaning of "12 2 % 48" is not clear from this text and may be a scanning error.*
3457501e-figure-06 (3457501e Figure 06)
This is a description of Losartan Potassium Tablets, USP with NDC number 58517-240-30, containing 30 tablets of 0mg strength. The remaining text seems to be garbled or not relevant.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
